SEC Form 4 · accession 0001209191-16-106152
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore H Stanley
Director
Period of report
Mar 4, 2016
Accepted (ET)
Mar 4, 2016 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2016 | M | 20,000 | $3.63 | A | 22,000 | D | |
| Common Stock | Mar 4, 2016 | S | 20,000 | $18.11 | D | 2,000 | D | |
| Common StockF1 | holding | — | — | — | 6,000 | I | by non-profit corporation | |
| Common StockF1 | holding | — | — | — | 10,200 | I | by limited partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $3.63 | Mar 4, 2016 | M | 20,000 | D | — | May 13, 2023 | Common Stock | 20,000 | 16,000 | D |
Explanation of responses
- F1The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
- F2The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.